Skip to main content

Health Care Utilization of Opioid Overdose Decedents with No Opioid Analgesic Prescription History

Journal of Urban Health volume 96, pages 38–48 (2019)Cite this article

Abstract

Opioid overprescribing is a major driver of the current opioid overdose epidemic. However, annual opioid prescribing in the USA dropped from 782 to 640 morphine milligram equivalents per capita between 2010 and 2015, while opioid overdose deaths increased by 63%. To better understand the role of prescription opioids and health care utilization prior to opioid-related overdose, we analyzed the death records of decedents who died of an opioid overdose in Illinois in 2016 and linked to any existing controlled substance monitoring program (CSMP) and emergency department (ED) or hospital discharge records. We found that of the 1893 opioid-related overdoses, 573 (30.2%) decedents had not filled an opioid analgesic prescription within the 6 years prior to death. Decedents without an opioid prescription were more likely to be black (33.3% vs 20.2%, p < .001), Hispanic (16.3% vs 8.8%, p < .001), and Chicago residents (46.8% vs 25.6%, p < .001) than decedents with at least one filled opioid prescription. Decedents who did not fill an opioid prescription were less likely to die of an overdose involving prescribed opioids (7.3% vs 19.5%, p < .001) and more likely to fatally overdose on heroin (63% vs 50.4%, p < .001) or fentanyl/fentanyl analogues (50.3% vs 41.8%, p = .001). Between 2012 and the time of death, decedents without an opioid prescription had fewer emergency department admissions (2.5 ± 4.2 vs 10.6 ± 15.8, p < .001), were less likely to receive an opioid use disorder diagnosis (41.3% vs 47.5%, p = .052), and were less likely to be prescribed buprenorphine for opioid use disorder treatment (3.3% vs 8.6%, p < .001). Public health interventions have often focused on opioid prescribing and the use of CSMPs as the core preventive measures to address the opioid crisis. We identified a subset of individuals in Illinois who may not be impacted by such interventions. Additional research is needed to understand what strategies may be successful among high-risk populations that have limited opioid analgesic prescription history and low health care utilization.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Notes

  1. We are using the terminology CSMP to more accurately describe these databases, which house information about receipt of controlled substance prescriptions (as opposed to all prescriptions) that are obtained in retail pharmacies.

  2. AL, AR, AZ, CA, CO, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NE, NH, NV, NY, OH, OK, OR, PA, TN, TX, UT, VA, WI.

References

  1. Kochanek KD, Murphy S, Xu J, Arias E. Mortality in the United States, 2016. NCHS Data Brief. 2017;293:1–8.

    Google Scholar 

  2. Morone NE, Weiner DK. Pain as the fifth vital sign: exposing the vital need for pain education. Clin Ther. 2013;35(11):1728–32.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiat. 2014;71(7):821–6.

    Article  Google Scholar 

  4. Muhuri P, Gfroerer J, Davies M. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. 2013. Available at https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm. Accessed 1 March 2018.

  5. Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374(2):154–63.

    Article  PubMed  CAS  Google Scholar 

  6. Morgan L, Weaver M, Sayeed Z, Orr R. The use of prescription monitoring programs to reduce opioid diversion and improve patient safety. J Pain Palliat Care Pharmacother. 2013;27:4–9.

    Article  PubMed  Google Scholar 

  7. Dowell D, Zhang K, Noonan RK, Hockenberry JM. Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates. Health Aff (Millwood). 2016;35(10):1876–83.

    Article  Google Scholar 

  8. Patrick SW, Fry CE, Jones TF, Buntin MB. Implementation of prescription drug monitoring programs associated with reductions in opioid-related death. Health Aff (Millwood). 2016;35(7):1324–32.

    Article  Google Scholar 

  9. Reifler LM, Droz D, Bailey JE, Schnoll SH, Fant R, Dart RC, et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Med. 2012;13:434–42.

    Article  PubMed  Google Scholar 

  10. Patrick SW, Carrie EF, Jones TF, Buntin MB. Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff. 2016;35(7):1324–32.

    Article  Google Scholar 

  11. Bryce P. Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction. 2017;112(10):1773–83.

    Article  Google Scholar 

  12. Paulozzi LJ, Kilbourne EM, Desai HM. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12:747–54.

    Article  PubMed  Google Scholar 

  13. Li G, Brady JE, Lang BH, Giglio J, Wunsch H, DiMaggio C. Prescription drug monitoring and drug overdose mortality. Injury Epidemiol. 2014;1(9):9.

    Article  Google Scholar 

  14. Brady JE, Wunsch H, Dimaggio C, Lang BH, Giglio J, Li G. Prescription drug monitoring and dispensing of prescription opioids. Public Health Rep. 2014;129(2):139–47.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Green TC, Bowman S, Davis C, Los C, McHugh K, Friedmann PD. Discrepancies in addressing overdose prevention through prescription monitoring programs. Drug Alcohol Depend. 2015;153:355–8.

    Article  PubMed  Google Scholar 

  16. Guy GP Jr, Zhang K, Bohm MK, et al. vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66:697–704. https://doi.org/10.15585/mmwr.mm6626a4.

  17. Overdose Death Rates. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed 4/1/2018; 2018.

  18. 2017 State of Illinois Comprehensive Opioid Data Report. Springfield, IL: Illinois Department of Public Health; 2017. Available at http://www.dph.illinois.gov/sites/default/files/publications/publicationsdoil-opioid-data-report.pdf. Accessed 13 Feb 2018.

  19. Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–6.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. In: Phillips JK, Ford MA, Bonnie RJ, editors. Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Washington, DC: National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; 2017. Available at https://www.ncbi.nlm.nih.gov/pubmed/29023083. Accessed 23 Feb 2018.

  21. Davoli M, Bargagli AM, Perucci CA, Schifano P, Belleudi V, Hickman M, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007;102(12):1954–9.

    Article  PubMed  Google Scholar 

  22. Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51–5.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Winkler WE. String comparator metrics and enhanced decision rules in the Fellegi Sunter model of record linkage. In: Proceedings of the Section on Survey Research Methods. Alexandria, VA: American Statistical Association; 1990.

  24. Abbasi AB, Clark H, Agbodo N. Learning algorithm to identify drugs involved in drug overdose deaths from literal text on death certificates. West Palm Beach, FL: Council of State and Territorial Epidemiologists; 2018.

    Google Scholar 

  25. Fentanyl: a briefing guide for first responders. Washington, DC: U.S. Department of Justice, Drug enforcement administration; 2017. Archived at: https://www.nvfc.org/wp-content/uploads/2018/03/Fentanyl-Briefing-Guide-for-First-Responders.pdf. Accessed 25 Dec 2017.

  26. Epidemiology report: increase in overdose deaths involving opioids – Chicago 2015–2016. Chicago, IL: Chicago Department of Public Health; 2017. Available athttps://www.cityofchicago.org/content/dam/city/depts/cdph/tobacco_alchohol_and_drug_abuse/2016ChicagoOpioidReport.pdf. Accessed Accessed 14 March 2018.

  27. Health Resources & Services Administration. Defining rural population. https://www.hrsa.gov/ruralhealth/about-us/definition/index.html. Accessed 1 April 2018.

  28. Cicero TJ, Kasper ZA, Ellis MS. Increased use of heroin as an initiating opioid of abuse: further considerations and policy implications. Addict Behav. 2018;87:267–71.

    Article  PubMed  Google Scholar 

  29. CDC. Data resources: analyzing prescription data and morphine milligram equivalents (MME). https://www.cdc.gov/drugoverdose/resources/data.html. Accessed 8/22/2017; 2017.

  30. Surratt HL, Kurtz SP, Buttram M, Levi-Minzi MA, Pagano ME, Cicero TJ. Heroin use onset among nonmedical prescription opioid users in the club scene. Drug Alcohol Depend. 2017;179:131–8.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Quinones S. Dreamland: the true tale of America’s opiate epidemic. New York, NY: Bloomsbury Press; 2015.

    Google Scholar 

  32. Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–74.

    Article  PubMed  Google Scholar 

  33. Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350:h2698.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1–2):8–18.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid prescribing at hospital discharge contributes to chronic opioid use. J Gen Intern Med. 2016;31(5):478–85.

    Article  PubMed  Google Scholar 

  36. Hill MV, Stucke RS, Billmeier SE, Kelly JL, Barth RJ Jr. Guideline for discharge opioid prescriptions after inpatient general surgical procedures. J Am Coll Surg. 2018;226(6):996–1003.

    Article  PubMed  Google Scholar 

  37. Chen J, Vargas-Bustamante A, Mortensen K, Ortega AN. Racial and ethnic disparities in health care access and utilization under the affordable care act. Med Care. 2016;54(2):140–6.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Singhal A, Tien YY, Hsia RY. Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. PLoS One. 2016;11(8):e0159224.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299(1):70–8.

    Article  PubMed  CAS  Google Scholar 

  40. Wells K, Klap R, Koike A, Sherbourne C. Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. Am J Psychiatr. 2001;158(12):2027–32.

    Article  PubMed  CAS  Google Scholar 

  41. Stein BD, Gordon AJ, Sorbero M, Dick AW, Schuster J, Farmer C. The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone. Drug Alcohol Depend. 2012;123(1–3):72–8.

    Article  PubMed  CAS  Google Scholar 

  42. Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015–2016. NCHS Data Brief. 2017;(289):1–8.

  43. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017. Available at https://www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed 12 Feb 2018.

  44. Cicero TJ, Ellis MS, Kasper ZA. Increases in self-reported fentanyl use among a population entering drug treatment: the need for systematic surveillance of illicitly manufactured opioids. Drug Alcohol Depend. 2017;177:101–3.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors were funded by the University of Chicago Institute of Politics (ABA), NIDA UG3DA044829 (MTP), and AHRQ R00HS022433 (MTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Affiliations

  1. University of Chicago Pritzker School of Medicine, Chicago, IL, USA

    Ali B. Abbasi

  2. Illinois Department of Public Health, Chicago, IL, USA

    Ali B. Abbasi, Jennifer E. Layden & Mai T. Pho

  3. Center for Multi-System Solutions to the Opioid Epidemic, American Institutes for Research, Chicago, IL, USA

    Elizabeth Salisbury-Afshar

  4. Division of Patient Safety and Quality, Illinois Department of Public Health, Chicago, IL, USA

    Dejan Jovanov

  5. Prescription Monitoring Program, Illinois Department of Human Services, Chicago, IL, USA

    Craig Berberet

  6. Cook County Chief Medical Examiner, Chicago, IL, USA

    Ponni Arunkumar

  7. Department of Emergency Medicine, Cook County Health and Hospitals System, Chicago, IL, USA

    Steven E. Aks

  8. Section of Infectious Diseases and Global Health, University of Chicago Medicine, Chicago, IL, USA

    Mai T. Pho

Authors
  1. Ali B. Abbasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Salisbury-Afshar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dejan Jovanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Craig Berberet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ponni Arunkumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Steven E. Aks
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jennifer E. Layden
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mai T. Pho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ali B. Abbasi.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abbasi, A.B., Salisbury-Afshar, E., Jovanov, D. et al. Health Care Utilization of Opioid Overdose Decedents with No Opioid Analgesic Prescription History. J Urban Health 96, 38–48 (2019). https://doi.org/10.1007/s11524-018-00329-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11524-018-00329-x

Keywords

  • Opioid overdose
  • Drug overdose prescription opioids
  • Heroin
  • Fentanyl
  • Controlled substance monitoring programs